Diphenhydramine Completed Phase 4 Trials for Urinary Incontinence (UI) / Clostridium Botulinum Toxin Adverse Reaction / Parkinson's Disease (PD) / Neurogenic Bladder Treatment

Indications	Status	Purpose	Phase
DBCOND0030460 (Urinary Incontinence (UI)) DBCOND0054107 (Clostridium Botulinum Toxin Adverse Reaction) DBCOND0053495 (Parkinson's Disease (PD)) DBCOND0033269 (Neurogenic Bladder)	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT01421719	Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease	Botulinum toxin type A (DB00083) Diphenhydramine (DB01075)